Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Williams

Showing results (251-260 of 286) with videos related to

Pageof 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1988
Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group StudyF M Torti, L D Shortliffe, R D Williams, et al.
The Journal of Urology|June 1, 1995
Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter studyF Steinbach, A C Novick, H Zincke, et al.
The Journal of Urology|January 1, 1992
Phase 1 trial of oral bropirimine in superficial bladder cancerM F Sarosdy, D L Lamm, R D Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administrationH B Muss, J J Costanzi, R Leavitt, et al.
Cancer|August 26, 1998
Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetideG H Hinkle, J K Burgers, C E Neal, et al.
Cancer Research|October 23, 1997
Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferationL G Boros, J Puigjaner, M Cascante, et al.
Neuroscience|February 18, 2006
Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesteraseZ Xie, W O Adamowicz, W D Eldred, et al.
BJU International|December 19, 2000
Biomarker distribution after injection into the canine prostate: implications for gene therapyD R Siemens, T Iwasawa, J C Austin, et al.
Science (New York, N.Y.)|November 11, 1994
Functional consequences of posttranslational isomerization of Ser46 in a calcium channel toxinS D Heck, C J Siok, K J Krapcho, et al.
American Journal of Clinical Oncology|April 1, 1997
Adenocarcinoma of the prostate: innovations in managementZ Petrovich, L Baert, M A Bagshaw, et al.
Pageof 29

Showing results (251-260 of 286) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1988
Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group StudyF M Torti, L D Shortliffe, R D Williams, et al.
The Journal of Urology|June 1, 1995
Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter studyF Steinbach, A C Novick, H Zincke, et al.
The Journal of Urology|January 1, 1992
Phase 1 trial of oral bropirimine in superficial bladder cancerM F Sarosdy, D L Lamm, R D Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administrationH B Muss, J J Costanzi, R Leavitt, et al.
Cancer|August 26, 1998
Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetideG H Hinkle, J K Burgers, C E Neal, et al.
Cancer Research|October 23, 1997
Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferationL G Boros, J Puigjaner, M Cascante, et al.
Neuroscience|February 18, 2006
Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesteraseZ Xie, W O Adamowicz, W D Eldred, et al.
BJU International|December 19, 2000
Biomarker distribution after injection into the canine prostate: implications for gene therapyD R Siemens, T Iwasawa, J C Austin, et al.
Science (New York, N.Y.)|November 11, 1994
Functional consequences of posttranslational isomerization of Ser46 in a calcium channel toxinS D Heck, C J Siok, K J Krapcho, et al.
American Journal of Clinical Oncology|April 1, 1997
Adenocarcinoma of the prostate: innovations in managementZ Petrovich, L Baert, M A Bagshaw, et al.
Pageof 29